UCLA Team Builds Microfluidic Platform for Measuring Protein Kinase Activity

The platform, which the scientists used to measure ABL kinase activity in BCR-ABL-positive leukemia patient samples, could potentially be expanded into a multiplex version for use in high-throughput kinase studies, said one of its developers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.